Search CommunityWalk:



15601 Crabbs Branch Way
Rockville, MD 20855, USA

Category: Diagnostic/Imaging

Used in the following map:

Maryland Biotech Industry Map

Principio is a biotechnology company that develops and manufactures novel, proprietary molecular imaging agents and therapeutic radiopharmaceuticals for the treatment of cancer. It was founded by Joe Hernandez.

Principio is mainly focused on: 1) Molecular Imaging Radiopharmaceuticals - radioactive drugs that target specific proteins or biochemical processes that permit the visualization of disease using PET or SPECT scanners; 2) Therapeutic Radiopharmaceuticals - radioactive drugs that selectively target cancer cells to deliver lethal cellular radiation for therapeutic benefit; and 3) Near Infrared (NIR) Molecular Imaging Agents - NIR molecules target cancer tissue and provide a real-time image of the tumors during surgery using NIR cameras for precise tumor extraction.

Principio's product pipeline includes: Visinol(TM) - for the imaging of EBV associated cancer which include most lymphomas, stomach cancer, nasopharyngeal cancer and AIDS related lymphomas; Prostavis(TM) - for the imaging of prostate cancer via a prostate cancer specific receptor; Curinol(TM) - for the molecular radiotherapy of EBV associated cancers; Prostara(TM) - for the molecular radiotherapy of prostate cancer via the via a prostate cancer specific receptor; and Nirlux(TM) - for real-time guided surgery of prostate cancer using NIR.

Principio has an agreement with Johns Hopkins Sidney Kimmel Comprehensive Cancer Center.